China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report

Bulletin Express

Apr 23

On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General Meeting, as well as the related Proxy Form, are now accessible on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).

In parallel, the Environmental, Social and Governance Report 2025 has been released and can be downloaded from the same online platforms under the “Investor Relations” section.

Registered shareholders who prefer hard copies of the newly published materials—or any future corporate communications—can request printed versions by:

• Submitting a written notice at least 10 days in advance to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong; • Sending an email to ChinaShineway.ecom@computershare.com.hk, indicating name, address and the specific request; or • Calling the registrar’s customer service hotline at (852) 2862 8555 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.

The notification was issued by Company Secretary Lee Bun Ching Terence on behalf of China Shineway Pharmaceutical Group Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1123088178"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123088178\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123088178?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123088178","market":"us","top_or_hot":-1,"title":"China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report","media":"Bulletin Express","content":"<p>On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General Meeting, as well as the related Proxy Form, are now accessible on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).</p>\n<p>In parallel, the Environmental, Social and Governance Report 2025 has been released and can be downloaded from the same online platforms under the “Investor Relations” section.</p>\n<p>Registered shareholders who prefer hard copies of the newly published materials—or any future corporate communications—can request printed versions by:</p>\n<p>• Submitting a written notice at least 10 days in advance to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong;  \n• Sending an email to ChinaShineway.ecom@computershare.com.hk, indicating name, address and the specific request; or  \n• Calling the registrar’s customer service hotline at (852) 2862 8555 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.</p>\n<p>The notification was issued by Company Secretary Lee Bun Ching Terence on behalf of China Shineway Pharmaceutical Group Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Shineway Pharmaceutical publishes 2025 Annual Report, AGM documents and ESG Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General Meeting, as well as the related Proxy Form, are now accessible on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).</p>\n<p>In parallel, the Environmental, Social and Governance Report 2025 has been released and can be downloaded from the same online platforms under the “Investor Relations” section.</p>\n<p>Registered shareholders who prefer hard copies of the newly published materials—or any future corporate communications—can request printed versions by:</p>\n<p>• Submitting a written notice at least 10 days in advance to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong;  \n• Sending an email to ChinaShineway.ecom@computershare.com.hk, indicating name, address and the specific request; or  \n• Calling the registrar’s customer service hotline at (852) 2862 8555 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.</p>\n<p>The notification was issued by Company Secretary Lee Bun Ching Terence on behalf of China Shineway Pharmaceutical Group Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1123088178","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123088178","pubTimestamp":1776938719,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"神威药业发布2025年年报、股东周年大会文件及ESG报告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"On 24 April 2026, China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the Circular and Notice of the forthcoming Annual General Meeting, as well as the related Proxy Form, are now accessible on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).\nIn parallel, the Environmental, Social and Governance Report 2025 has been released and can be downloaded from the same online platforms under the “Investor Relations” section.\nRegistered shareholders who prefer hard copies of the newly published materials—or any future corporate communications—can request printed versions by:\n• Submitting a written notice at least 10 days in advance to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong;  \n• Sending an email to ChinaShineway.ecom@computershare.com.hk, indicating name, address and the specific request; or  \n• Calling the registrar’s customer service hotline at (852) 2862 8555 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.\nThe notification was issued by Company Secretary Lee Bun Ching Terence on behalf of China Shineway Pharmaceutical Group Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}